BUZZ-U.S. STOCKS ON THE MOVE-Sarepta, Sprint, KaloBios, Mentor Graphics
(For faster updates on individual market-movers, Eikon users please use search string "STXBZ US"; for the Day Ahead newsletter, link.reuters.com/mex49s; for the Morning News Call newsletter, link.reuters.com/nex49s) U.S. stock indexes rose on Friday and were on track for their best weekly performance since October. The Dow Jones industrial average was up 0.96 percent at 17,903.55, the S&P 500 was up 0.69 percent at 2,095.66 and the Nasdaq Composite was up 0.64 percent at 5,106.267.
** BIOMARIN PHARMACEUTICAL INC, $98.595, -4.38 pct
** SAREPTA THERAPEUTICS INC, $32.9017, +26.21 pct
** PTC THERAPEUTICS INC, $28.5, -5.38 pct
U.S. Food and Drug Administration staff reviewers said clinical data to date did not merit approving the drug developer's muscle-wasting disorder drug.
Shares of Sarepta, which is developing rival product for DMD, rose. Shares of PTC, whose experimental DMD drug has also failed a late-stage study, fell.
** SPRINT CORP, $3.81, -5.93 pct Continued...